Join
Live feed
·
PRReleasevia Quantisnow
Gyre Therapeutics Inc. logo

Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline

ByQuantisnow·Wall Street's wire, on your screen.
GYRE· Gyre Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GYRE (Gyre Therapeutics Inc.) and more on Quantisnow.